Neuropsychiatric Effects of Deep Brain Stimulation in Patients With Parkinson's Disease
This study is enrolling participants by invitation only.
Sponsor:
University of California, San Diego
Collaborator:
National Alliance for Research on Schizophrenia and Depression
Information provided by (Responsible Party):
Adam Aron, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT01306539
First received: February 28, 2011
Last updated: March 26, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Stimulation of the subthalamic nucleus will have effects on various aspects of neuropsychiatric function.
| Condition | Intervention | Phase |
|---|---|---|
|
Parkinson's Disease |
Procedure: Stimulation of the subthalamic nucleus |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Basic Science |
| Official Title: | Neuropsychiatric Effects of Deep Brain Stimulation in Patients With Parkinson's Disease |
Resource links provided by NLM:
Further study details as provided by University of California, San Diego:
Primary Outcome Measures:
- behavioral task performance [ Time Frame: 1 to 2 hours ] [ Designated as safety issue: No ]Participants will complete behavioral tasks at each of three visits to assess the effects of stimulation settings on task performance. At each research visit, behavior will be assessed beginning at 1 hour after the stimulation is adjusted to the experimental settings. Stimulation settings will be returned to each patient's treatment levels at the culmination of each visit.
| Estimated Enrollment: | 45 |
| Study Start Date: | July 2008 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Deep Brain Stimulation
Parkinson's patients with deep brain stimulation in the subthalamic nucleus.
|
Procedure: Stimulation of the subthalamic nucleus
Stimulation is delivered to the subthalamic nucleus at experimentally prescribed settings.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Participants diagnosed with idiopathic Parkinson's disease that meet criteria for treatment of their disease with STN-DBS. Participants will be selected for this study without regard for age (provided they are older than 18), gender or ethnic background.
- Participants must have undergone subthalamic nucleus DBS surgery and be receiving treatment at the Scripps Clinic in La Jolla, CA
Exclusion Criteria:
- Patients under 18 years old.
- Patients with mini-mental status scores below 26/30.
- Patients with known psychiatric disease.
- Patients who are too infirm, demented or dysarthric to clearly understand the consenting process, task instructions, or to communicate verbally regarding participation or non-participation.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01306539
Locations
| United States, California | |
| Scripps Clinic Torrey Pines | |
| La Jolla, California, United States, 92092 | |
Sponsors and Collaborators
University of California, San Diego
National Alliance for Research on Schizophrenia and Depression
Investigators
| Principal Investigator: | Adam Aron, PhD | University of California, San Diego |
More Information
Publications:
| Responsible Party: | Adam Aron, Professor, University of California, San Diego |
| ClinicalTrials.gov Identifier: | NCT01306539 History of Changes |
| Other Study ID Numbers: | HSC-07-4849 |
| Study First Received: | February 28, 2011 |
| Last Updated: | March 26, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of California, San Diego:
|
deep brain stimulation subthalamic nucleus |
Additional relevant MeSH terms:
|
Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases |
ClinicalTrials.gov processed this record on May 16, 2013